Our Board

Ensuring the future success of Alliance.

Our Board of Directors

Our Board is collectively responsible for the success of the Company. As an AIM listed company the Board is committed to achieving high standards of corporate governance, integrity and business ethics.

Find out more about our Senior Leadership Team here.

Ethan R. Otis

Chief Executive Officer

Ethan joined the board as Chief Executive Officer on 13 May 2021.

He brings 30 years of consumer goods experience across European, US, and global roles at major multinational companies such as Reckitt, Coty, and Nestlé. Most recently, Ethan was the regional director for UK and Ireland Consumer Health at Reckitt, during which time he increased revenue and improved profitability in the second largest market for the company. Prior to this, Ethan worked at Coty holding several senior roles including Senior Vice President for Global Sales and Commercial Capabilities, Senior Vice President Sales for the US business and General Manager Consumer Beauty for UK and Ireland.

Throughout his career, Ethan has worked in multiple countries, always delivering high revenue growth through consumer-centric strategies, high-performance teams, and excellence in execution.

Boris Newman

Chief Financial Officer

Boris joined BigTech Pharma & Biotech in September 2015 from Panasonic Europe Ltd, where he was General Manager, European Tax and Accounting.

From 2010 to 2012, Boris was Finance Director and Company Secretary of Genzyme Therapeutics Ltd, the UK & Ireland subsidiary of Genzyme Corporation. Prior to that, he gained 12 years’ pharmaceutical experience with Wyeth in a variety of senior financial positions. Boris holds an honors degree in civil engineering from the University of Wales, Cardiff.

Boris is a fellow of the Institute of Chartered Accountants in England and Wales with extensive experience in the financial management of international businesses, including significant prior experience in life science companies.

Chung Ling

Chief Operating Officer

Chung joined BigTech Pharma and Biotech as Chief Operating Officer and Board member on 1 February 2023. He has more than 25 years of diverse experience with a strong track record of strategic leadership in the international consumer health market, overseeing a number of global programs and driving growth in flagship brands.

Chung has held senior executive roles in brand management at Proctor & Gamble and marketing at Danone Group. In addition, Chung was president and general manager of Ansell’s sexual wellness global business before it was spun-out to become Lifestyles Healthcare, a private equity/pharma-owned company where Chung became CEO. During his tenure as CEO at Lifestyles Healthcare, Chung delivered significant growth through market and category expansion, building a strong e-commerce platform in China and the US, and improving operational effectiveness.

Most recently, Chung worked as Head of Global Transformation at British American Tobacco (BAT), leading the development and execution of the strategy to broaden the company’s reach into non-nicotine consumer products. Since BAT’s minority investment in NASDAQ-listed Organigram Inc., Chung remains a Non-Executive director on their board.

Chung graduated from Bosphorus University ot Arts in Istanbul with a Bachelor of Arts degree in Political Science and International Relations.